These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 9473785)
1. Experimental chemotherapy of murine melanomas: is there a discrepancy compared to clinical experience? Borovanský J Neoplasma; 1997; 44(5):277-81. PubMed ID: 9473785 [TBL] [Abstract][Full Text] [Related]
2. Effects of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide, 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea, and L-phenylalanine mustard on B16, Cloudman S91, and Harding-Passey mouse melanomas. Hill HZ; Hill GJ; Miller CL; Pfaller M; Weiss K; Galin M Cancer Res; 1979 Mar; 39(3):934-9. PubMed ID: 427782 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of combinations of interferons and cytotoxic drugs in murine tumor models in vivo. Harrison SD; Stevens JJ; Waud WR; Dykes DJ; Schmid SM; Griswold DP J Biol Response Mod; 1990 Aug; 9(4):395-400. PubMed ID: 2118561 [TBL] [Abstract][Full Text] [Related]
4. Thymidine kinase in malignant melanoma. Borovanský J; Stríbrná J; Elleder M; Netíková I Melanoma Res; 1994 Oct; 4(5):275-9. PubMed ID: 7858409 [TBL] [Abstract][Full Text] [Related]
5. gamma-L-Glutaminyl-4-hydroxybenzene, an inducer of cryptobiosis in Agaricus bisporus and a source of specific metabolic inhibitors for melanogenic cells. Vogel FS; Kemper LA; Jeffs PW; Cass MW; Graham DG Cancer Res; 1977 Apr; 37(4):1133-6. PubMed ID: 403000 [TBL] [Abstract][Full Text] [Related]
6. Preclinical antitumor activity of bizelesin in mice. Carter CA; Waud WR; Li LH; DeKoning TF; McGovren JP; Plowman J Clin Cancer Res; 1996 Jul; 2(7):1143-9. PubMed ID: 9816280 [TBL] [Abstract][Full Text] [Related]
7. Cell cycle, melanin contents and apoptosis processes in B16 and Cloudman S91 mouse melanoma cells after exposure to cytostatic drugs. Olszewska-Słonina DM; Styczyński J; Czajkowski R; Drewa TA; Musiałkiewicz D Acta Pol Pharm; 2007; 64(5):469-78. PubMed ID: 18540169 [TBL] [Abstract][Full Text] [Related]
8. 3,4-Dihydroxybenzylamine: a dopamine analog with enhanced antitumor activity against B16 melanoma. Wick MM J Natl Cancer Inst; 1979 Dec; 63(6):1465-7. PubMed ID: 292814 [TBL] [Abstract][Full Text] [Related]
9. [Anti-invasive and anti-metastatic effect of ampelopsin on melanoma]. Zheng HQ; Liu DY Ai Zheng; 2003 Apr; 22(4):363-7. PubMed ID: 12703989 [TBL] [Abstract][Full Text] [Related]
10. Sequential chemoimmunotherapy with cisplatin, interferon-beta and interleukin-2 inhibits the growth of B16-F1 melanoma in syngeneic mice. Kubo H; Matsumoto K; Funahashi M; Takagi H; Kitajima Y; Taniguchi S; Saida T Melanoma Res; 2000 Jun; 10(3):223-9. PubMed ID: 10890375 [TBL] [Abstract][Full Text] [Related]
11. Consideration of the subcutaneously implanted B16 melanoma as a screening model for potential anticancer agents. Griswold DP Cancer Chemother Rep 2; 1972 Nov; 3(1):315-24. PubMed ID: 4660734 [No Abstract] [Full Text] [Related]
12. Inhibition of mouse melanoma cell proliferation by corticotropin-releasing hormone and its analogs. Carlson KW; Nawy SS; Wei ET; Sadée W; Filov VA; Rezsova VV; Slominski A; Quillan JM Anticancer Res; 2001; 21(2A):1173-9. PubMed ID: 11396159 [TBL] [Abstract][Full Text] [Related]
13. Preclinical efficacy and pharmacokinetics of AP5346, a novel diaminocyclohexane-platinum tumor-targeting drug delivery system. Rice JR; Gerberich JL; Nowotnik DP; Howell SB Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2248-54. PubMed ID: 16609041 [TBL] [Abstract][Full Text] [Related]
14. Inhibition and recovery of DNA synthesis in host tissues and sensitive and resistant B16 melanoma after 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea, a predictor of therapeutic efficacy. Brereton HD; Bryant TL; Young RC Cancer Res; 1975 Sep; 35(9):2420-5. PubMed ID: 1149044 [TBL] [Abstract][Full Text] [Related]
15. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth. Gil-Ad I; Shtaif B; Levkovitz Y; Nordenberg J; Taler M; Korov I; Weizman A Oncol Rep; 2006 Jan; 15(1):107-12. PubMed ID: 16328041 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy of a 188Re-labeled alpha-melanocyte-stimulating hormone peptide analog in murine and human melanoma-bearing mouse models. Miao Y; Owen NK; Fisher DR; Hoffman TJ; Quinn TP J Nucl Med; 2005 Jan; 46(1):121-9. PubMed ID: 15632042 [TBL] [Abstract][Full Text] [Related]
17. Are syngeneic mouse tumor models still valuable experimental models in the field of anti-cancer drug discovery? Darro F; Decaestecker C; Gaussin JF; Mortier S; Van Ginckel R; Kiss R Int J Oncol; 2005 Sep; 27(3):607-16. PubMed ID: 16077908 [TBL] [Abstract][Full Text] [Related]
18. [The inhibitory effect of recombinant fibronectin polypeptide CH50 on the growth of B16 melanoma]. Zhang H; Feng Z; Zhang G Zhonghua Zhong Liu Za Zhi; 1999 Nov; 21(6):416-8. PubMed ID: 11776614 [TBL] [Abstract][Full Text] [Related]
19. Anti-tumoural activity of peripheral blood mononuclear cells against melanoma cells: discrepant in-vitro and in-vivo effects. Joseph-Pietras D; Carlier A; Madoulet C; Albert P Melanoma Res; 2006 Aug; 16(4):325-33. PubMed ID: 16845328 [TBL] [Abstract][Full Text] [Related]
20. Tumour tissue is a source of gamma-glutamyl transpeptidase sialoform in the sera of melanoma-bearing mice. Melezínek I; Borovanský J; Elleder M; Bubnová E Melanoma Res; 1998 Feb; 8(1):39-45. PubMed ID: 9508375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]